Directors

Appointed December 2018 - term of office started 1 April 2019

Sir Jonathan is the Chair of Oxford University Hospitals NHS Foundation Trust.

He is Professor of Healthcare Law at University College London (UCL) and Chair of the Health Research Authority (HRA), which protects and promotes the interests of participants, patients and the public in health research.

Sir Jonathan served on local NHS boards in Hampshire and the Isle of Wight for more than 20 years up to March 2013 - including being the Chair of a group of primary care trusts, a strategic health authority and two provider trusts - and was a member of the panel of advisers to the Morecambe Bay Investigation, which reported in 2015.

He is also a past Chair of the Advisory Committee on Clinical Excellence Awards, the Nuffield Council on Bioethics, and the Human Genetics Commission.

Sir Jonathan was awarded a knighthood in the New Year Honours List in December 2018 for Services to Bioethics and Healthcare Law.

Appointed October 2015

Dr Bruno Holthof is the Chief Executive Officer (CEO) of Oxford University Hospitals NHS Foundation Trust (OUH). OUH employs 12,000 staff across four hospital sites and 44 other locations.

Before OUH, he was CEO of the Antwerp Hospital Network from January 2004 until September 2015. During this period, he transformed ZNA into the most profitable hospital group in Belgium.

Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations.

He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.

Appointed December 2009, reappointed January 2018 (current term ends November 2023)

Anne is a Chartered Accountant with more than 25 years of Board level experience in Executive and Non-executive roles. She has led successful finance and management teams in organisations ranging from owner-managed companies to large multi-nationals in sectors including manufacturing and banking.

Since August 2006 she has had a portfolio of Non-executive Directorships and financial consultancy roles across the public, private and social enterprise sectors.

She was appointed as Vice-Chairman by the Council of Governors on 30 October 2018 - the appointment took effect retrospectively from 20 September 2018.

In addition to her role at Oxford University Hospitals, Anne is a Trustee and Chair of the Audit Committee of Oxford Hospitals Charity.

She is also an independent member of the Audit and Risk Committee of the Department for International Development, a Director, Trustee and Chair of the Audit Committee of the International Network for the Availability of Scientific Publications (INASP Limited) and a Trustee of the charity, The Episcopal Church of South Sudan and Sudan University Partnership.

Appointed March 2019, term of office started 1 May 2019 (current term ends 2022)

Claire has a portfolio career consisting of a number of non-executive roles and some HR and leadership consulting. She is Deputy Chair of Scope, the national disability charity, and Chair of its People Committee. She is also a member of the Board of the National Nuclear Laboratory and Chair of their Remuneration Committee.

Claire was a Senior HR Manager for the FTSE100 drinks company Diageo, working across the UK, Europe and Asia, before joining Oxford Instruments, a leading international provider of hi-tech tools, systems and products, where she served on the Management Board for more than 10 years.

Appointed September 2017 (current term ends September 2023)

Paula is an experienced board director who has worked across the public and private sectors. Her executive career included serving as Chief Executive of the national regeneration agency, English Partnerships, and Corporate Finance and Group Reporting Director at Marks and Spencer plc.

Paula's current non-executive portfolio includes The Crown Estate, Michelmersh Brick Holdings plc and Aberforth Smaller Companies Trust plc. She has previously been a Non-executive Director of the National Audit Office, the Forensic Science Service and Skipton Building Society.

In 1997 Paula chaired the Coalfields Taskforce set up by Government to produce a programme of measures to regenerate former coalfield areas of England and help the communities which had suffered from the pit closures. She subsequently became a founding Trustee of the Coalfields Regeneration Trust.

Appointed September 2019, term of office started 28 October 2019 (current term ends 2022)

Sarah has extensive Board experience in plc, private and mutual entities focusing on operational property management and real estate development. Her current portfolio combines a mix of non-executive, consulting and Executive roles.

She is a Board member and Credit Committee lead for Newbury Building Society, a mutual organisation and one of the largest shared ownership lenders in the UK. She is also Chief Finance Officer for Modulous, a property technology start-up focused on transforming the design and delivery of high quality affordable housing.

Sarah is a Chartered Accountant and was Joint Chief Executive and Finance Director at Newbury Racecourse plc for 15 years. She was subsequently Chief Operating Officer for the Meyrick Group, a complex multi-site private property group with commercial, leisure and residential interests.

Appointed September 2019, term of office started 28 October 2019 (current term ends 2022)

Katie is an experienced IT professional who has spent 30 years in the industry, managing large teams across the world.

She holds non-executive roles at the Property Ombudsman and BPDTS, sitting on their Remuneration and Nominations committees, and she is also a Fellow of the British Computer Society.

Katie has been a charity Trustee and is heavily involved in sport, both participating and volunteering.

Appointed September 2018 (current term ends 31 August 2021)

Gavin is Professor of Medicine and Head of the Medical Sciences Division, University of Oxford.

He received his first degree from Cambridge in 1984 before moving to Oxford to complete his medical studies in 1987. He then completed training in general internal medicine and obtained a DPhil from Oxford University in 1998.

In 2004, Gavin was appointed to the Chair of Medicine at Hammersmith Hospital, Imperial College and became Dean of the Faculty of Medicine in 2015. He returned to Oxford as Head of the Medical Sciences Division in October 2017.

His research concerns the immunology of infectious diseases with an interest in dengue and Zika virus infections. He is a Fellow of both the Academy of Medical Sciences and the Royal College of Physicians, and was a Senior Investigator in the National Institute for Health Research.

Appointed September 2019, term of office started 1 December 2019 (current term ends 2022)

Professor Schapira was appointed as a Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery, Queen Square in 1988, and to the University Chair of Clinical Neurosciences at the University College London (UCL) Institute of Neurology in 1990.

He is vice dean of UCL Medical School and director of the UCL Royal Free campus.

His research interests focus on neurodegenerative disease, particularly Parkinson's and other movement disorders. He is the principal investigator on the Medical Research Council and EU H2020 programmes for neurodegenerative diseases.

During his career he has won a number of awards for his research and was elected a Fellow of the Academy of Medical Sciences in 1999.

Professor Schapira has been a Non-executive Director of Royal Free London NHS Foundation Trust since 2009, in which role he chairs the Trust's Clinical Standards and Innovation Committee and is a member of the Remuneration Committee.

He also has extensive Board experience in the broader public sector including as a Non-executive Director on the Board of the Ministry of Justice, Office of the Public Guardian from 2012-18 and as a current member of the NHS Independent Reconfiguration Panel.

Appointed January 2021, term of office started 6 April 2021 (current term ends 2024)

Ash studied pharmacy at Portsmouth School of Pharmacy and, after graduating in 1983, he began his pharmacy career in Central London and opened the first of his three pharmacies in 1986. In early 2004, he was one of the first pharmacists to qualify as a supplementary prescriber and he qualified as an independent prescriber in June 2007.

Ash has been Chair of the National Pharmacy Association's Board, is a past President, Assembly and English Pharmacy Board Member of the Royal Pharmaceutical Society, and is currently a Vice President of the International Pharmacy Federation.

He has held a number of roles with Lambeth Clinical Commissioning Group including Clinical Network Lead and Professional Executive Committee Chair, and received an OBE for Services to Pharmacy and the NHS.

Appointed January 2021, term of office started 1 June 2021 (current term ends 2024)

Joy is the CEO of brap, a national equalities and human rights charity. Her area of expertise is leadership and organisational development and she applies this lens to the work that brap does with organisations, boards and leadership teams.

Joy's background is in anti-discriminatory practice and application. Her expertise has been sought after and recognised on numerous occasions by the Department of Health, Cabinet Office, Department of Education, Care Quality Commission and others.

As a lifelong learner, Joy has an MSc in Organisational Development and Learning, a Certificate in Education PGCE, a Postgraduate Diploma in Multicultural Education, and a Certificate in Process Work (from the Deep Democracy Institute - Oregon).

Joy is a member of the NHS Leadership Faculty and currently delivers a range of inclusive leadership programmes, including the Stepping Up leadership development programme for aspiring black, Asian and minority ethnic (BAME) colleagues in the health sector. She is also a Visiting Professor at Middlesex University.

Apppointed October 2016

Jason is a graduate of the University of Oxford, where he completed a doctorate in modern history.

His extensive career experience includes three years as the Deputy Finance Director at University College London Hospitals NHS Foundation Trust, and roles within HM Treasury and major audit and professional services companies.

He was previously the Director of Finance, Reporting and Risk at the foundation trust regulator, Monitor.

Appointed September 2017

Sam is an experienced Chief Nurse who worked at the Heart of England NHS Foundation Trust for eight years, where she held the role of Chief Nurse for four years.

Sam has also worked in a number of other trusts, including Shrewsbury and Telford and Frimley Park.

Sam has a strong focus on nursing and midwifery education, having worked in both Trust and University education roles in her earlier career.

Appointed September 2018

Meghana joined the Trust in January 2019 from University Hospitals Coventry and Warwickshire (UHCW) NHS Trust where she was Chief Medical Officer and Deputy Chief Executive.

Her clinical background is in obstetrics and gynaecology, and in fact she was an SHO and registrar at the John Radcliffe and Churchill hospitals in Oxford during her training.

Meghana became a Consultant Obstetrician and Gynaecologist, then Clinical Director, and finally Divisional Director at Milton Keynes NHS Foundation Trust before becoming Chief Medical Officer at UHCW in 2012.

She has been Professor of Practice in the Institute of Digital Health at Warwick University since 2015, has a prize MBA from Oxford Brookes University, and is a Senior Founding Fellow of the Faculty of Medical Leadership and Management.

Sara Randall was appointed to the substantive role of Chief Operating Officer in June 2019 having previously been Acting Chief Operating Officer and Acting Director of Clinical Services.

Sara was Deputy Director of Clinical Services for Oxford University Hospitals from November 2011, prior to which she was Executive Director of Operations and Performance of the Nuffield Orthopaedic Centre NHS Trust.

She originally trained and worked as a nurse before moving into operational management roles.

Appointed November 2019

Terry joined the Trust in February 2020 from The Hillingdon Hospitals NHS Foundation Trust where he was Director of People and Organisational Development.

Prior to this role he was Director of Workforce at Kingston Hospital NHS Foundation Trust and Associate Director of HR at Barts Health NHS Trust.

He has held a number of other senior HR positions in NHS trusts, as well as spending a year on secondment at the Department of Health as a National HR Advisor.

Terry is a Fellow of the Chartered Institute of Personnel and Development (CIPD), has completed the Top Manager Programme with the King's Fund, and is a certified Coach and Mediator.

Appointed October 2019

David is accountable for digital technology, applications and data.

David provides leadership for strategy, information and the digital transformation of the Trust and its relationships with external partners, acting as Trust lead on developing integrated partnerships in particular with the Oxfordshire place-based system. David is also the Trust lead on all Freedom of Information matters and is the Senior Information Risk Manager for the Trust.

David joined the Trust in October 2019 from Liverpool University Hospitals NHS Foundation Trust and Liverpool Women's NHS Foundation Trust where he was the Chief Information Officer at both trusts.

Prior to his roles in Liverpool David worked as National ICT Manager for the Welsh Ambulance Service and Head of Informatics for Cheshire and Wirral Partnership NHS Foundation Trust where he commenced in 2004 after 10 years in the commercial sector.

David holds a MSc. In Health Informatics and is a Fellow of the British Computer Society.

Appointed May 2011

Eileen began with the NHS as a graduate management trainee, following a career in postgraduate academic scientific research.

She has a range of NHS management experience, predominantly at Director level, encompassing Clinical Governance, Corporate Governance, Risk Management and Assurance.

Eileen is an active participant in the national governance agenda as an invited speaker on risk, governance and assurance topics and has a strong interest in influencing national policy.

She previously held Director-level roles at University Hospitals Birmingham, Heart of England and Guy's and St Thomas'.